Reinhardt, Kristin
Stückrath, Kathrin
Hartung, Carolin
Kaufhold, Sandy
Uleer, Christoph
Hanf, Volker
Lantzsch, Tillmann
Peschel, Susanne
John, Jutta
Pöhler, Marleen
Bauer, Marcus
Bürrig, Friedrich Karl
Weigert, Edith
Buchmann, Jörg
Kantelhardt, Eva Johanna
Thomssen, Christoph
Vetter, Martina http://orcid.org/0000-0002-6642-9585
Funding for this research was provided by:
Martin Luther University Halle Wittenberg (FKZ 25/36)
Bundesministerium für Bildung und Forschung (e:Med FKZ: 031A429)
Universitätsklinikum Halle (Saale)
Article History
Received: 29 March 2022
Accepted: 14 May 2022
First Online: 24 October 2022
Change Date: 27 January 2023
Change Type: Update
Change Details: Missing Open Access funding information has been added in the Funding Note.
Declarations
:
: CT reports reports support form: Martin Luther University Halle-Wittenberg, Arbeitsgemeinschaft Gynäkologische Onkologie e.V., American Diagnostica, BIOMED BMH4 - 98 - 9418, honoraria from: Amgen, AstraZeneca, Celgene, Daiichi-Sankyo, Eisai, Gilead, Lilly, MSD, NanoString, Novartis, Pfizer, Pierre Fabre, Puma, Sanofi-Aventis, Roche, Vifor, Seagen. All other authors have no relevant financial or non-financial interests to disclose.
: This study was performed in line <i>with the principles of the Declaration of Helsinki.</i> The study protocol was approved by the Ethical Board of the Medical Faculty of the Martin Luther University Halle Wittenberg.
: All patients signed a written informed consent.